| Title |
The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases
|
|---|---|
| Published in |
Drug Safety, November 2014
|
| DOI | 10.1007/s40264-014-0239-7 |
| Pubmed ID | |
| Authors |
Hazel Mae A. Abraham, C. Michael White, William B. White |
X Demographics
The data shown below were collected from the profiles of 45 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 13 | 29% |
| United States | 4 | 9% |
| Peru | 2 | 4% |
| Mexico | 2 | 4% |
| Bolivia, Plurinational State of | 2 | 4% |
| Canada | 2 | 4% |
| India | 2 | 4% |
| Ecuador | 1 | 2% |
| United Arab Emirates | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 15 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 76% |
| Practitioners (doctors, other healthcare professionals) | 6 | 13% |
| Scientists | 5 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 295 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 293 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 40 | 14% |
| Student > Master | 32 | 11% |
| Researcher | 29 | 10% |
| Student > Ph. D. Student | 29 | 10% |
| Other | 20 | 7% |
| Other | 49 | 17% |
| Unknown | 96 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 67 | 23% |
| Pharmacology, Toxicology and Pharmaceutical Science | 55 | 19% |
| Biochemistry, Genetics and Molecular Biology | 13 | 4% |
| Agricultural and Biological Sciences | 12 | 4% |
| Chemistry | 11 | 4% |
| Other | 23 | 8% |
| Unknown | 114 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#976,290
of 26,017,215 outputs
Outputs from Drug Safety
#75
of 1,888 outputs
Outputs of similar age
#12,163
of 374,881 outputs
Outputs of similar age from Drug Safety
#1
of 16 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,888 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.